ILMA Compoundings - March 2021 - 29

Continued from page 27
general counsel is inviting lawsuits
to challenge Boeing and subsequent
decisions, giving the cases time to
work through the system to the NLRB
soon after the board flip. Many of

the rules that seem to be no-brainer
lawful rules were considered unlawful
pre-Boeing, and with a heavy emphasis
on union rights on the campaign trail,
this administration will see a pendulum shift toward labor groups.

Levetown serves as associate
counsel to ILMA through
Bassman, Mitchell, Alfano
& Leiter Chtd.
He may be reached at 202-466-6502 or
mlevetown@bmalaw.net.

Continued from page 26
protected unpaid leave for employees
to recover from the vaccine's side effects.
There are other steps that employers can take. To the extent that
employees who experience side effects
are unable to work, consider not
scheduling them for the day after they
receive the second inoculation or give
them PTO for that day. It seems only
logical that employees will be less
interested in getting the COVID-19
vaccine if they believe they will not
get paid or will have to use banked
PTO to recover from the shot's side
effects. Some employers are providing
additional PTO to employees who
voluntarily choose to get vaccinated.
However, be aware that vaccination
incentive strategies could create legal
risks for employers, so consult first

with your legal counsel about implementing such strategies. The main
issue here is whether the incentive,
whether formal or informal, would be
considered a " wellness program " by
the EEOC.
Think about some other practical
measures, such as asking employees
within the same units or departments
to stagger their vaccine appointments,
particularly for the second inoculation.
Lastly, most employees will receive
a card or document evidencing that
they have received the COVID-19
vaccine. Vaccine records are " health
records " under various laws, so
employers need to be cautious in
determining what information they
need from employees as proof of
their being vaccinated. While the
EEOC says that asking an employee

to show proof of vaccination is not a
disability-related inquiry, follow-up
questions, such as asking a worker
why he or she did not receive a
vaccination, may elicit information
about a disability and subject the
employer to Americans With Disabilities Act standards.
When I put these two inquiries
together, it is important to not let
down the guard and fail to remind
employees to take other reasonable
COVID-19 precautions, such as
washing hands, covering coughs and
sneezes and staying home when sick.
Keep taking those shots!
Leiter serves as general
counsel to ILMA, representing
the Association since 1981.
He may be reached at
202-466-6502 or jleiter@bmalaw.net.

ADVERTISERS INDEX
COMPANY NAME

Ergon, Inc.

AD PAGE #

CONTACT

PHONE

EMAIL

5

Kathy Potts

601-933-3148

kathy.potts@ergon.com

HollyFrontier Lubricants & Specialty Products

Inside Front

Robert Plummer

484-362-0610

robert.plummer@hollyfrontier.com

HollyFrontier Lubricants & Specialty Products

28

Robert Plummer

484-362-0610

robert.plummer@hollyfrontier.com

IPAC, Inc.

7

Brian Cereghino

800-720-7949

bcereghino@ipac-inc.com

Motiva

Back Cover

Colleen Murphy Smith

713-427-3392

colleen.smith@motiva.com

Motiva

33

Colleen Murphy Smith

713-427-3392

colleen.smith@motiva.com

Vanderbilt Chemical

35

Kevin Delaney

203-853-1400

petro@vanderbiltchemicals.com

29



ILMA Compoundings - March 2021

Table of Contents for the Digital Edition of ILMA Compoundings - March 2021

ILMA Compoundings - March 2021 - Cover1
ILMA Compoundings - March 2021 - Cover2
ILMA Compoundings - March 2021 - 1
ILMA Compoundings - March 2021 - 2
ILMA Compoundings - March 2021 - 3
ILMA Compoundings - March 2021 - 4
ILMA Compoundings - March 2021 - 5
ILMA Compoundings - March 2021 - 6
ILMA Compoundings - March 2021 - 7
ILMA Compoundings - March 2021 - 8
ILMA Compoundings - March 2021 - 9
ILMA Compoundings - March 2021 - 10
ILMA Compoundings - March 2021 - 11
ILMA Compoundings - March 2021 - 12
ILMA Compoundings - March 2021 - 13
ILMA Compoundings - March 2021 - 14
ILMA Compoundings - March 2021 - D1
ILMA Compoundings - March 2021 - D2
ILMA Compoundings - March 2021 - D3
ILMA Compoundings - March 2021 - D4
ILMA Compoundings - March 2021 - D5
ILMA Compoundings - March 2021 - D6
ILMA Compoundings - March 2021 - D7
ILMA Compoundings - March 2021 - D8
ILMA Compoundings - March 2021 - D9
ILMA Compoundings - March 2021 - D10
ILMA Compoundings - March 2021 - D11
ILMA Compoundings - March 2021 - D12
ILMA Compoundings - March 2021 - D13
ILMA Compoundings - March 2021 - D14
ILMA Compoundings - March 2021 - D15
ILMA Compoundings - March 2021 - D16
ILMA Compoundings - March 2021 - D17
ILMA Compoundings - March 2021 - D18
ILMA Compoundings - March 2021 - 16
ILMA Compoundings - March 2021 - 17
ILMA Compoundings - March 2021 - 18
ILMA Compoundings - March 2021 - 19
ILMA Compoundings - March 2021 - 20
ILMA Compoundings - March 2021 - 21
ILMA Compoundings - March 2021 - 22
ILMA Compoundings - March 2021 - 23
ILMA Compoundings - March 2021 - 24
ILMA Compoundings - March 2021 - 25
ILMA Compoundings - March 2021 - 26
ILMA Compoundings - March 2021 - 27
ILMA Compoundings - March 2021 - 28
ILMA Compoundings - March 2021 - 29
ILMA Compoundings - March 2021 - 30
ILMA Compoundings - March 2021 - 31
ILMA Compoundings - March 2021 - 32
ILMA Compoundings - March 2021 - 33
ILMA Compoundings - March 2021 - 34
ILMA Compoundings - March 2021 - Cover3
ILMA Compoundings - March 2021 - Cover4
https://www.nxtbook.com/ygsreprints/ILMA/G126213ILMA_vol71_no6
https://www.nxtbook.com/ygsreprints/ILMA/G125546_ILMA_vol71_no5
https://www.nxtbook.com/ygsreprints/ILMA/G124996_ILMA_vol71_no4
https://www.nxtbook.com/ygsreprints/ILMA/G123886_ILMA_vol71_no3
https://www.nxtbook.com/ygsreprints/ILMA/G123315_ILMA_vol71_no2
https://www.nxtbook.com/ygsreprints/ILMA/G122980_ILMA_vol71_no1
https://www.nxtbook.com/ygsreprints/ILMA/G121540_ILMA_vol70_no11
https://www.nxtbook.com/ygsreprints/ILMA/G120882_ILMA_vol70_no10
https://www.nxtbook.com/ygsreprints/ILMA/G120035_ILMA_vol70_no9
https://www.nxtbook.com/ygsreprints/ILMA/G121XXX_ILMA_vol70_no8
https://www.nxtbook.com/ygsreprints/ILMA/G120XXX_ILMA_vol70_no7
https://www.nxtbook.com/ygsreprints/ILMA/G119XXX_ILMA_vol70_no6
https://www.nxtbook.com/ygsreprints/ILMA/G118112_ILMA_vol70_no5
https://www.nxtbook.com/ygsreprints/ILMA/G117382_ILMA_vol70_no4
https://www.nxtbook.com/ygsreprints/ILMA/G116888_ILMA_vol70_no3
https://www.nxtbook.com/ygsreprints/ILMA/G115555_ILMA_vol70_no2
https://www.nxtbook.com/ygsreprints/ILMA/G114774_ILMA_vol70_no1
https://www.nxtbook.com/ygsreprints/ILMA/g110500_ILMA_vol69_no12
https://www.nxtbook.com/ygsreprints/ILMA/g110500_ILMA_vol69_no11
https://www.nxtbook.com/ygsreprints/ILMA/g110500_ILMA_vol69_no10
https://www.nxtbook.com/ygsreprints/ILMA/g109884_ILMA_vol69_no9
https://www.nxtbook.com/ygsreprints/ILMA/g109284_ILMA_vol69_no8
https://www.nxtbook.com/ygsreprints/ILMA/g108494_ILMA_vol69_no7
https://www.nxtbook.com/ygsreprints/ILMA/g107507_ILMA_vol69_no6
https://www.nxtbook.com/ygsreprints/ILMA/g106483_ILMA_vol69_no5
https://www.nxtbook.com/ygsreprints/ILMA/g105803_ILMA_vol69_no4
https://www.nxtbook.com/ygsreprints/ILMA/g104743_ILMA_vol69_no3
https://www.nxtbook.com/ygsreprints/ILMA/g103647_ILMA_vol69_no2
https://www.nxtbook.com/ygsreprints/ILMA/g102869_ILMA_vol69_no1
https://www.nxtbook.com/ygsreprints/ILMA/g101930_ILMA_vol68_no12
https://www.nxtbook.com/ygsreprints/ILMA/g100836_ILMA_vol68_no11
https://www.nxtbook.com/ygsreprints/ILMA/g99200_ILMA_vol68_no10
https://www.nxtbook.com/ygsreprints/ILMA/g98468_ILMA_vol68_no9
https://www.nxtbook.com/ygsreprints/ILMA/g97711_ILMA_vol68_no8
https://www.nxtbook.com/ygsreprints/ILMA/G96767ILMA_vol68_no7
https://www.nxtbook.com/ygsreprints/ILMA/G95397ILMA_vol65_no6
https://www.nxtbook.com/ygsreprints/ILMA/G94323ILMA_vol68_no5
https://www.nxtbook.com/ygsreprints/ILMA/G93127_ILMA_vol69_no4
https://www.nxtbook.com/ygsreprints/ILMA/G91785_ILMA_vol68_no3
https://www.nxtbook.com/ygsreprints/ILMA/G90956_ILMA_vol68_no2
https://www.nxtbook.com/ygsreprints/ILMA/G89146_ILMA_vol68_no1
https://www.nxtbook.com/ygsreprints/ILMA/G87981_ILMA_vol67_no12
https://www.nxtbook.com/ygsreprints/ILMA/G85409_ILMA_vol67_no11
https://www.nxtbook.com/ygsreprints/ILMA/G83595_ILMA_vol67_no10
https://www.nxtbook.com/ygsreprints/ILMA/G81672_ILMA_vol67_no9
https://www.nxtbook.com/ygsreprints/ILMA/G80238_ILMA_vol7_no8
https://www.nxtbook.com/ygsreprints/ILMA/G79388_ILMA_vol7_no7
https://www.nxtbook.com/ygsreprints/ILMA/G78361_ILMA_vol7_no6
https://www.nxtbook.com/ygsreprints/ILMA/G77448_ILMA_vol7_no5
https://www.nxtbook.com/ygsreprints/ILMA/G75899_ILMA_vol67_no4
https://www.nxtbook.com/ygsreprints/ILMA/G75036_ILMA_vol67_no3
https://www.nxtbook.com/ygsreprints/ILMA/G72720_ILMA_vol67_no2
https://www.nxtbook.com/ygsreprints/ILMA/G72220_ILMA_vol67_no1
https://www.nxtbook.com/ygsreprints/ILMA/G70970_ILMA_vol66_no12
https://www.nxtbook.com/ygsreprints/ILMA/G69813_ILMA_vol66_no11
https://www.nxtbook.com/ygsreprints/ILMA/G67522_ILMA_vol66_no10
https://www.nxtbook.com/ygsreprints/ILMA/G66343_ILMA_vol66_no9
https://www.nxtbook.com/ygsreprints/ILMA/G64859_ILMA_vol66_no8
https://www.nxtbookmedia.com